NEUROLOGIA

FEBBRAIO 2026

HOT-TOPICS
Dott.ssa Stefania Dalise
Overview sessione “Hot Topics in BoNT Therapy”
Dott.ssa Marzia Millevolte 
Overview sessione “Adult spasticity”
Dott.  David Hernández
The broken patient pathway for patients with post-stroke spasticity and the goal of EPITOME study
Dott. Francesco Marenco
Effect of early use of botulinum toxin A on goal attainment in post-stroke spasticity
Persistence with botulinum neurotoxin type A and factors associated with discontinuation: a retrospective cohort study
Dott. Mirko Filippetti
Pathophysiology of muscle changes in patients with spasticity (including myopathy)
Dott. Franco Molteni
La riabilitazione del paziente e le nuove tecnologie
Dott. Marcello Esposito
Overview sessione “Cervical Dystonia”
Prof. Daniele Belvisi
Overview sessione “Focal Limb Dystonia and tremor”
Dott.ssa Martina Petracca
Overview sessione “Oromandibular Dystonia and Spasmodic Dysphonia”
Dott. Massimo Marano
Overview sessione “Hemifacial Spasm, Blepharospasm and Meige Syndrome”
Prof. Roberto Erro
Overview sessione “Analog vs Digital Using phenomenology and artificial intelligence/technology in the diagnosis of hyperkinetic movement disorders and its phenotypes”
Dott. Alberto Doretti
Il dolore: lo stato dell’arte e nuovi insights
Overview sessione “Pain”

GENNAIO 2024

BONT
Prof. Andrea Santamato
Università di Foggia, Policlinico Riuniti di Foggia,
Foggia, Italia
Il Patient Journey 

Safety Profile and Efficacy of High Dose AbobotulinumtoxinA In Adult Spasticity
Prof. Alessio Baricich
Azienda Ospedaliero Universitaria "Maggiore della Carità", Università del Piemonte Orientale,
Novara, Italia
La gestione del dolore
  • Pain Treatment Beyond Spasticity: The Role of AbobotulinumtoxinA in the Rehabilitation of Multiple Sclerosis
  • An Open Study of Botulinum Neutoxin Type A in the Treatment of Chronic Neuropathic Pain for One Year
Efficacia e utilizzo delle neurotossine botuliniche
  • Effectiveness of AbobotulinumtoxinA in Adults With Lower Limb Spasticity: Top Line Results from AboLish Observational Study
  • Botulinum Neurotoxin Underuse in Older Stroke Survivors: Insights from the French National Discharge Database
  • Botulinum Toxin and Multimodal Treatments for Functional Recovery in Poststroke Spasticity
Dott. Marcello Esposito
UOC Neurofisiopatologia, A.O.R.N. A. Cardarelli,
Napoli, Italia
La gestione del tremore
Dott. Rocco Quatrale
Ospedale dell'Angelo,
Venezia Mestre, Italia
Overview sessione “Oromandibular Dystonia”
Dott. Riccardo Marvulli
Policlinico Bari,
Bari, Italia
L’importanza della ricerca di base
  • BoNT Actions Beyond Neurons
  • BoNT-A as a Possible Treatment for Chronic Spinal Cord Injury
  • Botulinum Neurotoxin Type A Antinociceptive Activity in Spinal Cord and Trigeminal Sensory Nociceptive Nuclei Involves Central Trans-Synaptic Transport
Dott.ssa Maria Concetta Altavista
ASL Roma 1, Ospedale San Filippo Neri,
Roma, Italia
Overview sessione “Blepharospasm”
Dott.ssa Marzia Millevolte
Azienda Ospedaliero Universitaria delle Marche,
Ancona, Italia
Outcomes nel trattamento con tossina botulinica
  • Initial Assessment of The Validity and Inter-Rater Reliability For Early Recognition of Spasticity Using the Decision Tree Tool (1- REFER)
  • Outcomes Measurement and Goal-Setting Recommendations in the Multipattern Treatment of Shoulder-Spasticity With Botulinum Neurotoxin
  • Modelling Long-Term Outcomes for BoNT-A in Patients With Post-Stroke Spasticity
  • Impact of Patients Input on the Study Execution of a Prospective, Epidemiological Study Assessing the Proportion of Stroke Survivors Who Develop Problematic Post- Stroke Spasticity
Dott. Daniele Belvisi
Sapienza Università di Roma, Neuromed,
Pozzilli (IS), Italia
Distonia cervicale: hot topics
  • Overview sessioni dedicati alla Cervical Dystonia “advanced injection techinques” e Issues and insights”
Botulinum Neurotoxin Treatment Dynamics and Persistence Over 2 Years in Patients With Cervical Dystonia or Spasticity: A Retrospective Claims Database Analysis